| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |